Influence of age and shock severity on short-term survival in patients with cardiogenic shock

Jacob C Jentzer1,2, Benedikt Schrage3,4, David R Holmes1

  • 1Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Insights

Older patients with cardiogenic shock (CS) have lower survival rates, even with similar shock severity. Advanced age and higher shock stage significantly increase mortality risk in CS patients.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Critical Care Medicine

Background:

  • Cardiogenic shock (CS) is a critical condition with high mortality, particularly in older adults.
  • The impact of age on CS outcomes is debated, with uncertainty regarding the role of shock severity.

Purpose of the Study:

  • To investigate the association between patient age and cardiogenic shock severity.
  • To determine the impact of age and shock severity on 30-day mortality in CS patients.

Main Methods:

  • Retrospective analysis of 1749 CS patients from two centers (Mayo Clinic and University Clinic Hamburg).
  • Shock severity was classified using the Society for Cardiovascular Angiography and Intervention (SCAI) shock stages.
  • Cox proportional-hazards analysis was used to identify predictors of 30-day survival.

Main Results:

  • Older CS patients exhibited similar shock severity but had more comorbidities and worse renal function.
  • Thirty-day survival was 53.3% overall and decreased significantly with increasing age and SCAI shock stage.
  • Adjusted 30-day survival was incrementally lower in older age groups compared to those under 50.

Conclusions:

  • Older patients with CS face lower short-term survival despite comparable shock severity.
  • Increasing age and more severe shock (SCAI stages) are independently associated with higher mortality risk.
  • Optimal treatment strategies for elderly CS patients require further investigation.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
93
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
67
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
143
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.2K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
238
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
92